Keros Therapeutics logo
Keros Therapeutics KROS
$ 61.07 1.87%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Keros Therapeutics Operating Income 2011-2024 | KROS

Annual Operating Income Keros Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-170 M -115 M -56.4 M -46.7 M -10.6 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-10.6 M -170 M -79.7 M

Quarterly Operating Income Keros Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-50.4 M -48.5 M - -43.3 M -41.3 M -38.9 M - -28 M -30.7 M -24.1 M - -20.2 M -15.5 M -15.8 M - -11.9 M -10.9 M -10.5 M - -2.33 M -2.65 M -2.86 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-2.33 M -50.4 M -23.4 M